Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Fuji Pharma Co.,Ltd., 5% Increase in Ordinary Profit, Record High for The First Time in Eight Years, Dividend to Rise by 3 yen
4554 Fuji Pharma Co.,Ltd. 【J-GAAP】
Earnings ReportFuji Pharma Co.,Ltd. <4554> [TSE-P] announced its financial results after the market closed on November 12th (16:00). The consolidated ordinary profit for the fiscal year ending September 2024 decreased by 1.6% from the previous period to 4.44 billion yen. For the fiscal year ending September 2025, the profit is expected to grow by 5.3% to 4.68 billion yenExpected to reach record high profits for the first time in eight years. This will be the fifth consecutive term of revenue growth.
At the same time, the company has decided to increase the dividend this fiscal year to 45.5 yen, an increase of 3 yen from the previous fiscal year.
In the most recent three-month period, from July to September (4Q), the consolidated ordinary profit decreased to 1.47 billion yen, a 16.9% decrease compared to the same period last year. However, the operating profit margin rose from 12.8% in the same period last year to 12.8%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep, 2022 | 35,426 | 3,777 | 3,725 | 2,696 | 111.0 | 35 | Nov 10, 2022 | J-GAAP |
Sep, 2023 | 40,889 | 3,858 | 4,519 | 3,435 | 141.4 | 37 | Nov 9, 2023 | J-GAAP |
Sep, 2024 | 46,138 | 3,880 | 4,445 | 6,146 | 252.9 | 42.50 | Nov 12, 2024 | J-GAAP |
YoY | +12.8% | +0.6% | -1.6% | +78.9% | +78.9% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep, 2024 Guidance | 46,060 | 3,990 | 4,602 | 6,185 | 254.4 | 42.50 | May 9, 2024 | J-GAAP |
Sep, 2024 Results | 46,138 | 3,880 | 4,445 | 6,146 | 252.9 | 42.50 | Nov 12, 2024 | J-GAAP |
Revision Rate | +0.2% | -2.8% | -3.4% | -0.6% | -0.6% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 21,388 | 1,443 | 2,165 | 4,257 | 175.2 | 20 | May 9, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 26,150 | 2,380 | 2,330 | 1,650 | 67.9 | 20 | Nov 12, 2024 | J-GAAP |
YoY | +22.3% | +64.9% | +7.6% | -61.2% | -61.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep, 2023 | 40,889 | 3,858 | 4,519 | 3,435 | 141.4 | 37 | Nov 9, 2023 | J-GAAP |
Sep, 2024 | 46,138 | 3,880 | 4,445 | 6,146 | 252.9 | 42.50 | Nov 12, 2024 | J-GAAP |
Sep, 2025 Guidance | 53,360 | 4,850 | 4,680 | 3,380 | 139.0 | 45.50 | Nov 12, 2024 | J-GAAP |
YoY | +15.7% | +25.0% | +5.3% | -45.0% | -45.0% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Sep, 2023 | 11,407 | 1,455 | 1,778 | 1,453 | 59.8 | 12.8 | Nov 9, 2023 | J-GAAP |
Oct - Dec, 2023 | 10,746 | -140 | -96 | 2,739 | 112.7 | -1.3 | Feb 8, 2024 | J-GAAP |
Jan - Mar, 2024 | 10,642 | 1,583 | 2,261 | 1,518 | 62.5 | 14.9 | May 9, 2024 | J-GAAP |
Apr - Jun, 2024 | 11,767 | 772 | 802 | 653 | 26.9 | 6.6 | Aug 8, 2024 | J-GAAP |
Jul - Sep, 2024 | 12,983 | 1,665 | 1,478 | 1,236 | 50.9 | 12.8 | Nov 12, 2024 | J-GAAP |
YoY | +13.8% | +14.4% | -16.9% | -14.9% | -15.0% |
Related Articles
UNBANKED,INC., 84% Increase in Undisclosed Ordinary Profit for First Half
Kidswell Bio Corporation, The Current Fiscal Year's Net Income to Narrow
Virtualex Holdings,Inc., July-September (2Q) Ordinary Profit Increases by 45%
KAN-NANMARU CORPORATION, July-September (1Q) Ordinary Profit Loss Narrows
Nippon Chemical Industrial Co.,Ltd., The Current Fiscal Year Ordinary Profit Revised Upward by 24%, Dividend Revised Upward by 22 yen
INTERMESTIC INC., January-September (Third Quarter Cumulative) Ordinary Profit 5.3 billion yen, Exceeds Full-Year Plan
AOYAMA TRADING Co., Ltd., The Current Fiscal Year Ordinary Profit Revised Upward by 4%, Dividend Revised Upward by 66 yen
JFLA Holdings Inc., First Half Ordinary Profit Increases by 6.9 times, Exceeds Full-Year Plan
Landix Inc., First Half Ordinary Profit Increases by 23%, July-September Ordinary Profit Increases by 2.3 times
JUKI CORPORATION, The Current Fiscal Year Ordinary Profit Loss Widened in Downward Revision